• Researchers struggle to understand the immediate effects of COVID, with no clear census on the long-term neurological impact
• COVID-19 has shown itself to be unique in how it interacts with the brain
• Brain e-tattoos implanted in forehead will be next wave of innovation for neurology

Brain Scientific (OTCQB: BRSF) is meeting the growing need for improved brain monitoring with cost-efficient, disposable, and portable cutting-edge technology. This last year has seen an increased demand for disposable neurological technology accessible to all, adaptable for widespread use, and that provides quick, reliable information on the patient’s condition.

As the pandemic winds down, thanks to dedicated medical workers, social-distancing, mask-wearing and new vaccines, there are still many questions that need to be addressed.

The scientific world is only at the beginning of truly understanding the effects of COVID-19 on the brain. A year into the pandemic, researchers struggle to understand the immediate effects, with no clear census on the long-term impact. Neurological symptoms may go well beyond a loss of taste and smell or “brain fog” to problems with attention, concentration, and multitasking. The question is, how long will these symptoms last, and will patients eventually recover.

The Global Council on Brain Health (“GCBH”) has stated that critical research is needed in assessing how COVID-19 impacts later-in-life cognitive decline or dementia. It is not just the virus that needs to be studied, but also the impact of isolation during the pandemic on older adult brains.

COVID-19 has shown itself to be unique in how it interacts with the brain. Megakaryocytes, cells that produce platelets and primarily reside in bone marrow, have been found in the autopsied brains of COVID victims. This phenomenon has never been seen before. It may block blood flow to the brain and thereby be responsible for brain fog.

Figuring out why some patients are unaffected cognitively from COVID while others are left with significant and possibly long-term effects is essential in understanding this virus. More monitoring is needed to find the answers. That’s where Brain Scientific’s cutting-edge technology comes into play.

The NeuroEEG(TM) device is a portable, wireless, and compact device that acquires, records, transmits, and displays the wearer’s electrical brain activity. This device works in conjunction with the NeuroCap(TM), a hospital-grade disposable EEG headset featuring 19 active channels and 22 electrodes that comes in sizes for adults and pediatric patients. These devices are portable, making it simpler to take the needed tech to the patient rather than bringing the patient to the equipment.

The company is working on development of Brain E-Tattoo(TM) that in the future will provide access to long-term studies and inroads in helping identify root neurological problems. This tiny device will use graphene-based electrodes connected to the micro EEG clipped behind the ear that then transfers data to a cloud application. The data will be continuously analysed by artificial intelligence, which provides 24/7 uninterrupted monitoring.

 “COVID-19 put a spotlight on the outdated and inefficient EEG testing protocols,” said Boris Goldstein, BRSF co-founder and executive. “Disposable technology made a significant impact to ensure brain scans could occur safely during the pandemic. Now, brain e-tattoos implanted in the forehead will be the next wave of innovation for neurology. The advancement will allow for long-term monitoring capabilities and uninterrupted data collection from patients with neurological conditions. Clinicians will be able to identify brain wave activity beyond the clinical setting with no impact to the patient’s daily life.” 

Thanks to cutting-edge technology such as BRSF’s NeuroCap, NeuroEEG and e-Tattoo, the answers may just lie right around the corner.

For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.